terazosin
- Product NDC
- 60760-816
- 11-digit product format
- 607600816
- Labeler code
- 60760
- Product ID
- 60760-816_e1aad010-b3da-6cf4-e053-2a95a90a2786
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- St Mary's Medical Park Pharmacy
- Application
- ANDA075614
- Marketing category
- ANDA
- Marketing start
- 2021-04-30
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60760-816 | TERAZOSIN CAPSULE [ST MARY'S MEDICAL PARK PHARMACY] | 1 | Legacy NDC | 20220619_e1aadab7-3ddd-0bf6-e053-2995a90acb7a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-816-90 | 60760081690 | 90 CAPSULE in 1 BOTTLE, PLASTIC (60760-816-90) | 90 capsule | 2021-04-30 | 0000-00-00 | No | No | Current |